Viral hepatitis in practice

Supplements

	Viral hepatitis in prctice – Daklinza®▼(daclatasvir): up to the challenge of genotype 3 May 2016, Sponsored Supplement

	Viral hepatitis: current options, future directions – a report from the International Liver Congress 2015 August 2015, Sponsored Supplement

	Daklinza® (daclatasvir):the first approved NS5A inhibitor in the UK for the treatment of hepatitis C February 2015, Sponsored Supplement

	Treating hepatitis C – the cost of waiting, the value of action Winter 2014, Sponsored Supplement

	Hepatitis C: the new era of management – a report from the International Liver Congress 2014 July 2014, Volume 6 Number 1, Sponsored Supplement

	Hepatitis C in the UK: A real-world perspective Spring 2014, Sponsored Supplement Prescribing information can be found on the back page of the supplement.

	Hepatitis C – a report from the European Association for the Study of the Liver 2013 annual meeting November 2013, Volume 5 Number 2, Sponsored Supplement

Information for advertisers/sponsors
To find out more about supplement opportunities or request a copy of our supplement guidelines, contact Kirsty Haves at:

Viral hepatitis in practice was previously supported by Gilead Sciences from 2015 to 2016, by Gilead Sciences and Janssen in 2014, by Gilead Sciences and Roche Products in 2013 and by Gilead Sciences from 2009 to 2012.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsor, publisher, Editor or Editorial Board. Accordingly the sponsor, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Viral hepatitis in practice is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2019 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to:

ISSN 2041-1162 (Print) ISSN 2045-7863 (Online)